Buprenorphine has been shown to be effective for fentanyl users in the emergency room.

Published Date: 13 Mar 2023

A review of electronic medical records found similar associations between opioid-using patients who reported and did not report fentanyl use.

Read Full News

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

How Anesthesiologists Predict Who Will Throw Up After Surgery

— And how we prevent it

Dexamethasone, Ondansetron Show No Difference After Cesarean

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish Experts Expand Care After Perinatal Loss

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Acetaminophen and Autism: Data, Debate, and Risk

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

Palliative Care Use in Hospitalized Hematologic Malignancies

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

Todays Updates

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease Marco Meglio

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

Upadacitinib Feasible for Palmoplantar Pustulosis: David Gleeson, BM BCH David Gleeson, BM BCH

Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Todays Updates

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease Marco Meglio

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

Upadacitinib Feasible for Palmoplantar Pustulosis: David Gleeson, BM BCH David Gleeson, BM BCH

Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

— And how we prevent it

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

News All Time

Coma Therapy Tied to Poor Outcomes in Nonconvulsive SE

Patients with nonconvulsive status epilepticus treated with therapeutic coma experience markedly higher rates of complications and mortality than those not receiving the treatment.

Whole Person Approach to Pain Management for Vets in Hospice

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Axial PsA Diagnosis: Applying AXIS Evidence in Practice

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

Doc Sues Malpractice Insurer for Refusing to Settle Lawsuit

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

Cancer Pain Remains a Major Clinical Challenge

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

Outpatient Palliative Care Consult and End-of-Life Outcomes

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

French Experts Say Medical Hypnosis May Ease ENT Procedures

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

Inpatient Palliative Care in Gynecological Malignancies

This study evaluated the national prevalence, trends, and inpatient outcomes of palliative care use among women hospitalized with gynecological malignancies.

Half of Veterans With Stage IV Cancer Die Without Hospice

Hospice care improves symptom control, reduces ICU utilization, and raises family-rated quality of dying among patients with advanced cancer.

Disposables Dominate Cesarean Anesthesia Carbon Footprint

Disposable items account for the majority of anesthesia-related carbon emissions during cesarean delivery, with a notable portion coming from products that are opened but discarded without use.

Trust Is Earned, Not Assumed

Trust flows both ways between physicians and their patients, says John Whyte, MD, MPH, CEO and executive vice president of the American Medical Association. Dr Whyte shares how he seeks to build that trust.

Hallucinogens: Overhyped and Underwhelming

Enthusiasm for hallucinogens has surged, but has the evidence kept pace? Dr Nassir Ghaemi examines the research behind ketamine, psilocybin, and MDMA — and argues for a more critical look.

Medicine Is a Team Sport

John Whyte, MD, MPH, CEO and executive vice president of the AMA, shares his advice for new physicians on how to build trust with their patients.

Poor Function Before ICU Admission Tied to Later Death Risk

Frailty and functional dependency before admission are associated with an increased risk for mortality after admission to the ICU, although the evidence remains uncertain.

Social Egg Freezing: Choice, Business, or Burden?

Growing interest in egg preservation raises questions about access, affordability, informed consent, and whether workplace pressures shift reproductive responsibility onto women.

Booming Weight-loss Drug Demand in Brazil Fuels Thriving Black Market and Health Fears

When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the...

Recommended News For You

Certain surgical gestures during prostate removal linked to better sexual function recovery

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

Annual Cancer Report Highlights Advances, Funding Threats

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

Researchers discuss HER2-low and HER2-zero in breast cancer

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

"We Caught It Early": Advantage or Disadvantage?

Recommended Articles For You

Tumor Microenvironment Secretome Mapping in Cancer Biology 

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine 

Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

2.

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

5.

Common intracellular toxin could help fight leukemia

1.

Fibroma: Understanding the Causes, Symptoms, and Treatment Options

2.

Clonal Hematopoiesis and Thrombotic Risk Beyond Cancer: A Comprehensive Review for Clinicians

3.

Unlocking The Causes And Risk Factors Of Breast Cancer

4.

Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future

5.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

1.

International Conference on Oncology, Cardiology and Critical Care Policy

2.

International Conference on Innovations in Critical Care for Oncology and Cardiology

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Cancer Nursing and Hematology Support

1.

Thromboprophylaxis In Medical Settings

2.

The Role of Hemoglobin in Maintaining Healthy Oxygen Levels

3.

How Multidisciplinary Teams Support Modern Cancer Care

4.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

5.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot